))
It didn’t all change in March 2020. Not really. The UK high street has been in the throes of a gradual revolution for decades. From the rise of ecommerce, to the birth of mobile, social commerce, and a growing emphasis on experience, change has been underway for a while. In fact for many, the pandemic has acted as a wake-up call. Digital transformation was no longer a ‘nice to have’ but a matter of survival. Necessity sparked innovation and customers are enjoying more flexibility and conveni ...
How Sites and Investigators Are Reflecting on Decentralized Trial Models
Manage episode 340557803 series 2877522
Зроблено Citeline and Pharma Intelligence і знайдено завдяки Player FM та нашій спільноті. Авторські права належать видавцю, а не Player FM, і аудіоматеріали транслюються безпосередньо з сервера видавця. Натисніть на кнопку Підписатися, щоб слідкувати за оновленнями в Player FM або скопіюйте і вставте посилання на канал до іншої програми для подкастів.
• What are the benefits of the decentralized clinical trial (DCT) model? • What are the barriers to sites and investigators participating in DCTs? • What support measures are critical to DCT success? • What is the outlook for DCTs during the coming 3 – 5 years and how can sites and investigators contribute to their evolution? Listen to a lively discussion of these questions and more, as industry experts discuss DCT and hybrid clinical trial models. Download and listen to your free podcast from Scrip, presented in partnership with ICON.
1013 епізодів
